跳转至内容
Merck
CN

79266

Supelco

三甲基苯基氢氧化铵 溶液

~0.5 M (CH3)3N(OH)C6H5 in methanol, for GC derivatization, LiChropur

别名:

苯基三甲基氢氧化铵

登录查看公司和协议定价


About This Item

线性分子式:
(CH3)3N(OH)C6H5
CAS号:
分子量:
153.22
Beilstein:
3917033
MDL编号:
UNSPSC代码:
12000000
PubChem化学物质编号:
NACRES:
NA.22

等级

for GC derivatization

质量水平

表单

liquid

质量

LiChropur

反应适用性

reagent type: derivatization reagent
reaction type: Esterifications

浓度

~0.5 M (CH3)3N(OH)C6H5 in methanol

技术

gas chromatography (GC): suitable

杂质

≤0.2% halides (as chloride)

储存温度

2-8°C

SMILES字符串

[OH-].C[N+](C)(C)c1ccccc1

InChI

1S/C9H14N.H2O/c1-10(2,3)9-7-5-4-6-8-9;/h4-8H,1-3H3;1H2/q+1;/p-1

InChI key

HADKRTWCOYPCPH-UHFFFAOYSA-M

正在寻找类似产品? 访问 产品对比指南

一般描述

Trimethylphenylammonium hydroxide (TMAH) is a methylating reagent.

应用

Learn more in the Product Information
Suitable for the derivatization of amino acids, n-methyl and n-aryl carbamates and fatty acids, clonidine, and substituted phenylureas.
TMAH may be used as a 0.1 mole/litre solution in methanol to determine plasma concentrations of carbamazepine and other anticonvulsant drugs, including phenobarbital, diphenylhydantoin, primidone, and mephenytoin using Gas-Liquid Chromatography.

其他说明

可适用销售限制条款
Reagent for n-methyl and methyl esters.

法律信息

LiChropur is a trademark of Merck KGaA, Darmstadt, Germany

警示用语:

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1B - STOT SE 1

靶器官

Eyes

储存分类代码

3 - Flammable liquids

WGK

WGK 3

闪点(°F)

51.8 °F - closed cup

闪点(°C)

11 °C - closed cup

个人防护装备

Faceshields, Gloves, Goggles

法规信息

危险化学品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Simultaneous determination of carbamazapine ("Tegretol") and other anticonvulsants in human plasma by gas-liquid chromatography.
J C Roger et al.
Clinical chemistry, 19(6), 590-592 (1973-06-01)
Alec N Salt et al.
Journal of the Association for Research in Otolaryngology : JARO, 13(6), 771-783 (2012-09-13)
Perilymph pharmacokinetics was investigated by a novel approach, in which solutions containing drug or marker were injected from a pipette sealed into the perilymphatic space of the lateral semi-circular canal (LSCC). The cochlear aqueduct provides the outlet for fluid flow
Alec N Salt et al.
Hearing research, 232(1-2), 78-86 (2007-07-31)
Local delivery of drugs to the inner ear is increasingly being used in both clinical and experimental studies. Although direct injection of drugs into perilymph appears to be the most promising way of administering drugs quantitatively, no studies have yet
Anthony A Mikulec et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 30(2), 131-138 (2009-01-31)
Drugs applied to the middle ear enter perilymph through the bony otic capsule. Drugs applied intratympanically in humans are thought to enter the cochlea primarily through the round window membrane (RWM). Local drug treatments of the ear are commonly evaluated
Jeffrey T Auletta et al.
Chemico-biological interactions, 187(1-3), 135-141 (2010-05-25)
Acetylcholinesterase (AChE) contains a narrow and deep active site gorge with two sites of ligand binding, an acylation site (or A-site) at the base of the gorge and a peripheral site (or P-site) near the gorge entrance. The P-site contributes

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门